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Purpose: The purpose of this study was to evaluate the visual and refractive outcomes and 
rotational stability of the new aspheric Precizon® toric intraocular lens (IOL) for the correction 
of corneal astigmatism in cataract surgery.
Setting: Department of Ophthalmology, Hospital Geral de Santo António – Centro Hospitalar 
do Porto, EPE and Hospital de Pedro Hispano, Matosinhos, Portugal.
Design: This was a prospective clinical study.
Patients and methods: A total of 40 eyes of 27 patients with corneal astigmatism greater 
than 1.0 diopter (D) underwent cataract surgery with implantation of Precizon® toric IOL. IOL 
power calculation was performed using optical coherence biometry (IOLMaster®). Outcomes of 
uncorrected (UDVA) and best-spectacle corrected distance visual acuities (BCDVA), refraction, 
and IOL rotation were analyzed at the 1st week, 1st, 3rd, and 6th month’s evaluations.
Results: The median postoperative UDVA was better than preoperative best-spectacle corrected 
distance visual acuity (0.02 [0.06] logMAR vs 0.19 [0.20] logMAR, P0.001). At 6 months, 
postoperative UDVA was 0.1 logMAR or better in 95% of the eyes. At last follow-up, the mean 
spherical equivalent was reduced from -3.35±3.10 D to -0.02±0.30 D (P0.001) with 97.5% 
of the eyes within ±0.50 D of emmetropia. The mean preoperative keratometric cylinder was 
2.34±0.95 D and the mean postoperative refractive cylinder was 0.24±0.27 D (P0.001). The 
mean IOL rotation was 2.43°±1.55°. None of the IOLs required realignment.
Conclusion: Precizon® toric IOL revealed very good rotational stability and performance 
regarding predictability, efficacy, and safety in the correction of preexisting regular corneal 
astigmatism associated with cataract surgery.
Keywords: astigmatism, cataract surgery, toric intraocular lens, stability, implantation 
outcomes
Introduction
Astigmatism is an extremely common refractive error whose incidence increases with 
age with a prevalence of astigmatism 1 diopter (D) of around 31% of the population 
older than 40 years old.1 Approximately 30% of eyes scheduled for cataract surgery 
have a high level of preexisting corneal astigmatism and as both cataract and astig-
matism impair the quality of life of a patient, modern cataract surgery aims to treat 
both cataract and refractive errors with a single procedure.2–4
Various toric pseudophakic intraocular lenses (IOLs) are available for astigmatism 
correction during cataract surgery.5–9 Although new toric IOLs show good visual and 
refractive outcomes and rotational stability, misalignment keeps being the main fac-
tor for residual astigmatism and spectacle dependency after implantation of a toric 
IOL. It has been shown that every degree of misalignment results in a loss of up to 
3.3% of the IOL’s cylindrical power.10 The success of a toric IOL lies not only on the 
IOL stability in the capsular bag over time, but also on its tolerance to misalignment. 
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The aim of this study was to evaluate the visual and refrac-
tive outcomes and the rotational stability of the new aspheric 
Precizon® toric IOL after cataract surgery in patients with 
preexisting corneal astigmatism.
Patients and methods
This prospective noncomparative study included eyes that 
were implanted with Precizon® toric IOL after phacoemul-
sification surgery at Hospital Geral de Santo António – 
Centro Hospitalar do Porto, EPE in Oporto and Hospital de 
Pedro Hispano – Matosinhos Local Unity of Heath EPE in 
Matosinhos, between January 2014 and April 2014. This 
study followed the tenets of the Declaration of Helsinki 
and was approved by each local ethics committee of Centro 
Hospitalar do Porto, EPE and Hospital de Pedro Hispano. All 
patients provided written informed consent after receiving 
thorough explanation of the procedure.
The inclusion criteria were cataract and preexisting ker-
atometric astigmatism of at least 1.0 D. Exclusion criteria 
were glaucoma, irregular astigmatism, corneal disease, previ-
ous corneal or intraocular surgery, macular degeneration or 
retinopathy, and history of ocular inflammation.
Preoperative evaluation, iOl, and power 
calculation
All patients underwent an extensive evaluation that included 
medical history, refraction and monocular uncorrected 
(UDVA), and best-spectacle corrected (BCDVA) distance 
visual acuities measurements. The Early Treatment of 
Diabetic Retinopathy Study charts at 4 m and autoker-
atometry (KA-1000®) were used. In addition, slit-lamp 
examination, intraocular pressure (contact Goldmann 
tonometry), dilated fundoscopy (Goldmann 3 mirrors lens), 
macular evaluation using spectral-domain optical coherence 
tomography (Spectralis®), endothelial cell count (ECC) and 
morphology (ICONAN®), and corneal topography using 
Scheimpflug imaging (PentacamHR® [OCULUS Inc., WA, 
USA] or Sirius-CSO® [Scandicci, FI, Italy]) were performed. 
Keratometry (K) readings and Biometry measurements (eg, 
axial length and anterior chamber depth) used for IOL power 
calculation were obtained with optical coherence biometry 
(IOLMaster®, Carl Zeiss Meditec AG, Jena, Germany). The 
spherical power of the IOL was calculated using the SRK-T 
formula for IOL power calculation and the A-constant of 
118.5 for the toric IOL. The target postoperative spherical 
equivalent (SE) was the closest possible to emmetropia. Cal-
culations of the cylindrical power and axis placement were 
determined using the IOL manufacturer’s online calculator 
(PRECIZON™ Online Calculator, Ophtec BV, Groningen, 
the Netherlands, available from: http://calculator.ophtec.
com/. Accessed May 20, 2015), taking into account the 
data obtained with optical coherence biometry, the inci-
sion location as well as the estimate of surgically-induced 
astigmatism (SIA) personalized for each surgeon at the 
incision axis.
surgical technique
Before surgery, the 0°–180° axis was marked with the patient 
seated at the slit-lamp to avoid cyclotorsion using a gravity 
marker with a calibrated horizontal position (LRI Gravity 
marker, Rumex, Clearwater, FL, USA). Intraoperatively, 
the main incision location and the desired implantation axis 
were marked on the limbus after correctly aligning a Mendez 
ring to the primary marks to ascertain the intended angle 
of placement, according to preoperative plan. Phacoemul-
sification was performed through a 2.4-mm clear cornea 
incision. After a continuous curvilinear capsulorrhexis of 
approximately 5.5 mm and hydrodissection were performed, 
the cataract was removed using a phaco-chop technique 
(Infiniti, Alcon, Inc., Hünenberg, Switzerland; Bausch & 
Lomb Incorporated, Bridgewater, NJ, USA). The toric IOL 
was implanted in the capsular bag using a disposable injec-
tor and cartridge system Dualtec™ Kit (Ophtec BV) before 
ophthalmic viscosurgical device (OVD, sodium hyalorunate 
1.0%, Provisc®) was removed. After OVD withdrawal, the 
IOL was rotated to its final position by exactly aligning 
the toric reference lines on the IOL with the limbal implanta-
tion marks. The postoperative treatment included antibiotic, 
corticosteroids, and nonsteroidal anti-inflammatory eye drops 
in all patients.
intraocular lens
The IOL used in this study was Precizon® toric IOL Model 
565 (Ophtec BV), a 1 piece hydrophilic acrylic, monofocal, 
aspheric IOL with a transitional conic toric surface (patent 
pending), and plate-loop design. It is a foldable IOL and has 
a supporting closed loop-haptic design with no angulation, 
a biconvex 360° square edged 6.0 mm optic, and an overall 
diameter of 12.5 mm. During IOL implantation, the available 
spherical power ranged from +10 to +30 D (0.5 D increments) 
and cylinder power from 1 to 6 D (0.5 D increments).
Postoperative assessment
Postoperative examinations were performed at 1 week and 
1, 3, and 6 months. The examinations included UDVA, 
BCDVA, subjective refraction, and slit-lamp examination 
with IOP measurement. At 6 months, postoperative corneal 
astigmatism was assessed using the same device used for 
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IOL calculation (IOLMaster®, Carl Zeiss Meditec AG) to 
calculate the surgically-induced corneal astigmatism (SICA). 
Rotation of the IOL was assessed as follows: slit-lamp 
digital photographs in retroillumination of the IOL were 
obtained after full mydriasis, as the IOL marks are located 
at the periphery of the IOL optic, and digital image analysis 
was performed (Figure 1). Postoperative photographs were 
compared between them and also with the picture indicating 
the torus position at the end of the surgery. Clockwise (CW) 
rotation was counted as negative rotation and counterclock-
wise (CCW) as positive rotation. Absolute rotation was 
used to compare the observation periods. Patient satisfaction 
was rated as very poor, poor, moderate, good, or very good 
at 3rd month. ECC and morphology were analyzed at 6th 
month. Complications during follow-up were recorded.
Vector analysis of astigmatism changes
At 6 months of follow-up, the overall accuracy of the astig-
matism correction was calculated by using a vector analysis 
according to Alpins and Goggin.11 The Alpins method uses 
three astigmatism parameters: preoperative, target, and 
achieved astigmatism. The postoperative refractive astig-
matism was compared with the preoperative keratometric 
astigmatism (IOLMaster®, Carl Zeiss Meditec AG). The 
target astigmatism was 0, because emmetropia was the goal 
in all patients. Refractive astigmatism data were calculated 
to the corneal plane for a back vertex distance of 12.0 mm. 
Three fundamental vectors were determined and evaluated: 
target-induced astigmatism (TIA) vector, which represents 
the change (by magnitude and axis) the surgery was intended 
to induce for each treatment; the SIA vector, which is the 
astigmatic change the surgery actually achieved; and the 
difference vector, which represents the astigmatism change 
between the achieved and the target astigmatism outcome, 
and is an absolute measure of success and is preferably 0. 
The following parameters derived from the relationship 
between these vectors were calculated: the magnitude of 
error, defined as the arithmetic difference between the 
magnitudes of the SIA and the TIA, that is positive for 
overcorrection and negative for undercorrection; the angle 
of error, which is the angle between the SIA and TIA vec-
tors, that is positive if the achieved correction is CCW to 
the intended axis, and negative if the achieved correction is 
CW to the intended axis; the flattening effect, which is the 
amount of astigmatism reduction achieved at the intended 
(TIA) meridian; the flattening index is calculated by divid-
ing the flattening effect of the TIA and is preferably 1.0; the 
correction index was calculated by the ratio of the magnitude 
of the SIA to the magnitude of the TIA, and is preferably 
1.0. If an overcorrection occurred it is greater than 1.0 and 
if an undercorrection was found it is less than 1.0; the index 
of success was calculated by dividing the difference vector 
by the TIA and is a relative measure of success which is 
preferably 0.12,13 In this study, the TIA was the corneal 
astigmatism measured by optical biometry.
statistical analysis
Categorical variables are presented as frequencies and 
percentages, and continuous variables as means and standard 
deviations, or medians and interquartile ranges for variables 
with skewed distributions. Normal distribution was checked 
using Shapiro–Wilk test or skewness and kurtosis.
Paired sample t-test was used to compare the number 
of endothelial cells between preoperative examinations 
and 6 months postoperative examinations. Cylinder and SE 
values were compared using one-way analysis of variance 
for repeated measures. Sphericity could not be assumed, so 
Greenhouse-Geisser was used as a correction factor. Post hoc 
comparisons were performed using Bonferroni test. UDVA 
and BCDVA examinations were compared using Friedman’s 
analysis of variance and post hoc analysis were performed 
using Wilcoxon signed-rank test, considering Bonferroni 
correction (α/number of comparisons).
All reported P-values are two-tailed, with a P-value of 
0.05 indicating statistical significance. Analyses were per-
formed using SPSS, version 22.0.
Results
This study comprised 40 eyes of 27 consecutive patients 
submitted to cataract surgery and Precizon® toric IOL implan-
tation. Table 1 shows the demographic and preoperative data 
of our sample.
Figure 1 Postoperative digital analysis of Precizon® toric iOl rotation.
Abbreviation: iOl, intraocular lens.
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Visual acuity and refraction
Visual and refractive outcomes are shown in Table 2. The 
UDVA and BCDVA improved significantly after surgery.
At last follow-up, 6 months after surgery, the median UDVA 
was 0.02 (0.06) logMAR (range 0.16 to -0.10 logMAR), 
significantly better than the median preoperative BCDVA 
that was 0.19 (0.20) logMAR (range 0.70–0.0 logMAR) 
(P0.001). The UDVA was equal or better than preoperative 
BCDVA in all the eyes. The final UDVA was 0.1 logMAR 
or better in 95% of the eyes (n=38) and 0.0 logMAR or better 
in 42.5% (n=17) (Figure 2).
The mean SE significantly decreases from -3.35±3.10 D 
(range -11.5 to +1.88 D) preoperatively to -0.02±0.30 D 
(range -0.75 to +0.75 D) at last follow-up (P0.001). The 
mean SE remained stable after the 1st week evaluation 
(Table 2). After 6 months, 97.5% of the eyes (n=39) were 
within ±0.50 D of the target emmetropia and 100% (n=40) 
within ±0.75 D.
The mean corneal astigmatism targeted to be corrected 
was 2.34±0.95 D (range 1.12−4.81) and the mean residual 
refractive astigmatism was 0.24±0.27 D (range 0.0−1.0 D) 
(P0.001). The mean refractive astigmatism remained stable 
after the 1st week evaluation (Table 2). At last follow-up, 
the mean refractive astigmatism was 0.50 D in 95% of 
the eyes (n=38), and 1.00 D in 100% of the eyes (n=40) 
(Figure 3).
At 6 months, the mean postoperative corneal cylinder 
was 2.32±1.03 D (range 0.87−5.07), with no statistical 
difference when compared with the mean preoperative cor-
neal cylinder (P=0.56), being the mean SICA that was not 
incorporated in IOL power calculation of 0.02±0.24 D, that 
was not significantly different from 0.
Table 3 and Figures 4 and 5 show the results of the vec-
torial astigmatism analysis at 6 months of follow-up. The 
mean angle of error indicated that the mean angle of SIA 
vector was -0.70°±3.62° CW to the TIA vector. The mean 
flattening effect was 2.23±0.85 D.
iOl rotation
Table 4 shows the absolute misalignment of the toric IOL 
between the observation periods. IOL rotation occurred 
mainly within the 1st week after surgery (P0.0125) and 
minimal rotation was observed afterwards, with just one 
IOL rotation between the 3rd- and 6th-month evaluations 
(P0.0125) (Figure 6). A mean rotation relative to the 
intended axis of 2.43°±1.55° (range 0°–6°) was recorded at 
the final visit (P0.001). During follow-up, IOL rotation 
was 4° in 90% of the eyes (n=36) with no IOL rotation more 
than 6°. At 6 months, rotation was CW in 16 eyes, CCW in 
17 eyes, and 7 IOLs were in the intended position.
Patient satisfaction
Satisfaction with visual acuity and quality of vision was rated 
as very good by all the patients.
eCC and complications
The mean ECC decreased from 2,458±381 cells/mm2 
to 2,423±389 cells/mm2 (range 1,693−3,188 cells/mm2) 
(P0.05), which amounts to a 1.42% decrease in ECC, as 
shown in Table 2.
Table 1 Preoperative data (27 patients, 40 eyes)
Variable Mean ± SD, median (IQR), absolute number (%)a Range
age (years) 63.4±11.1 48, 83
sex
Female 16 (59.3)
Male 11 (40.7)
eye
left 10 (25)
right 4 (10)
Both 26 (65)
refractive astigmatism (D) 2.38±0.97 1.0, 5.0
spherical equivalent -3.35±3.10 -11.5, 1.88
UDVa (logMar) 1 (0.79) 0.30, 1.40
BCDVa (logMar) 0.19 (0.20) 0.0, 0.70
Corneal astigmatism (D) 2.34±0.95 1.12, 4.81
sphere iOl power (D) 17.6±3.79 10.75, 27.5
Cylinder iOl power (D) 3.28±1.33 1.50, 6.0
Predicted residual astigmatism (D) 0.13±0.16 0.0, 0.81
endothelial cell count (eCC) 2,458±381 1,724, 3,200
Notes: aMean ± sD or median (interquartile range) for gaussian or not gaussian variables, respectively.
Abbreviations: BCDVa, best-spectacle corrected distance visual acuity; D, diopter; iOl, intraocular lens; UDVa, uncorrected distance visual acuity; sD, standard deviation; 
iQr, interquartile range.
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All surgeries were uneventful. No complication occurred 
during the follow-up. No patient required IOL repositioning 
due to misalignment. No posterior capsule opacification was 
observed.
Discussion
High levels of corneal astigmatism are prevalent in a signifi-
cant proportion of the population, and its correction along 
with cataract surgery can allow higher rates of spectacle 
independence. Limbal relaxing incisions or opposite cor-
neal incisions may be performed during cataract surgery; 
however, they depend on the corneal healing response that is 
relatively unpredictable.14,15 Laser refractive surgery can be 
used when not contraindicated in the correction of residual 
refractive errors but may be complicated with dry eye, wound 
healing problems, and infections and is an expensive and 
not widely available tool.16 Toric IOL is the correction of 
choice of high levels of astigmatism during cataract surgery 
toric IOL implantation is a predictable method with minimal 
impact to the cornea; however, careful patient selection, 
correct measurement of corneal astigmatism, IOL calcula-
tion, IOL alignment during surgery, rotational stability, and 
tolerance to misalignment of the IOL are crucial factors in its 
efficacy. Patient with regular bowtie astigmatism benefits the 
most with toric IOL implantation, and irregular astigmatism 
is a relative contraindication although in selected cases with 
mild to moderate amounts of irregular astigmatism toric IOLs 
have achieved good functional results.17,18 In our study, all 
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Figure 2 Cumulative postoperative distance visual acuities (UDVa – uncorrected; 
BCDVa – best-spectacle corrected) at 6 months evaluation (6 m) (n=40 eyes).
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patients had corneal tomography using Scheimpflug imaging; 
and if irregular astigmatism was detected, then the patient 
was not included.
As manual and automated keratometry and corneal 
topography have been shown to measure comparable astig-
matism values, we preferred to use IOL Master automated 
keratometry for accurate IOL calculation, which is the cus-
tomized choice in our practice for nontoric IOL spherical 
power calculation.19,20
Calculations of the IOL spherical and cylindrical power 
and axis placement were determined using the valuable tool of 
IOL manufacturer’s online calculator taking into account the 
estimate of SICA and incision location. However, several fac-
tors influence SICA and make it difficult to predict and the most 
accurate method in practice is to use the surgeon’s personalized 
amount of SICA and was the one used in this study.5,21,22
Performance of toric IOLs is extremely dependent on 
correct positioning at the time of the surgery and on the early 
postoperative rotation stability of the IOL.
Rotation of the IOL occurs mainly in the early post-
operative period before the capsular bag healing process 
is completed and several mechanisms such as OVD 
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Figure 3 astigmatism shift during the follow-up in all 40 eyes implanted with Precizon® toric iOl during cataract surgery.
Abbreviations: iOl, intraocular lens; Preop, preoperative; w, week; m, month.
Table 3 astigmatism analysis by alpins method (40 eyes)
Parameter
Target-induced astigmatism
arithmetic mean magnitude (D) ± sD 2.34±0.95
Vector mean (D @ degrees) 0.17 @ 89.9
surgically induced astigmatism
arithmetic mean magnitude (D) ± sD 2.24±0.84
Vector mean (D @ degrees) 0.16 @ 83.6
Difference vector
arithmetic mean magnitude (D) ± sD 0.24±0.27
Vector mean (D @ degrees) 0.06 @ 40
Mean magnitude of error (D) ± sD -0.10±0.28
Mean arithmetic angle of error (degrees) ± sD -0.70±3.61
Mean absolute angle of error (degrees) ± sD 1.90±0.69
Mean flattening index ± sD 0.99±0.27
Mean correction index ± sD 0.95±0.19
Mean index of success ± sD 0.12±0.14
Abbreviations: D, diopter; sD, standard deviation.
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Figure 4 single-angle polar plots for the target-induced astigmatism (Tia) vector 
at 6 months follow-up.
Abbreviations: arith mean, arithmetic mean; ax, axis.
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clearance, IOP fluctuations, capsulorrhexis size and cen-
tration, and IOL design and material influence early rota-
tion stability.5,23,24 Late rotation due to capsule shrinkage 
and compression of the IOL haptics may occur in certain 
IOL designs and materials. Closed loop-haptics of the IOL 
used in this study are longer than plate-haptics, which 
should gave good initial friction and the loops have a 
second insertion on the IOL that might resist later capsular 
compression and subsequent rotation.23–25 In our study, 
rotation occurred mainly within 1st week after surgery 
with a median of 1°, with negligible rotation afterwards. 
This result might confirm that capsule bag had fused by 
the 1st week, and is apparent that most of IOL misalign-
ment is mainly due to factors other than IOL rotation 
such as errors with marking and implantation procedures, 
incomplete clearance of OVD trapped behind the IOL 
and postoperative axis measurement as mentioned in the 
literature.5,12,23–29
The very low mean rotation at 6 months from the intended 
axis in our study of 2.43°±1.55°, with IOL rotation 4° in 
90% of the eyes and with no IOL rotation more than 6° was 
excellent and in accordance with very good rotational stabil-
ity reported with other loop-haptic acrylic IOLs and slightly 
superior to plate-loop IOLs.5–9,27–30
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Figure 5 single-angle polar plots for the surgically-induced astigmatism (sia) vector 
at 6 months follow-up.
Abbreviations: arith mean, arithmetic mean; ax, axis.
Table 4 Postoperative intraocular lens rotation
Variable Intended axis–1 week 1 week–1 montha 1 month–3 monthsa 3 months–6 monthsa Intended axis–6 months
Median (IQR)b P-valuec Median (IQR)b P-valuec Median (IQR)b P-valuec Median (IQR)b P-value
rotation 1 (1) 0.0125 0.0 (1) ns 0.0 (1) 0.0125 0 (0) 0.001
Notes: alOl absolute rotation (degrees) between each two consecutive moments. bMedian (iQr). cAdjusted P-value significance level (0.0125). Bonferroni’s correction for 
multiple comparisons. Comparisons between each two consecutive moments.
Abbreviations: IOL, intraocular lens; IQR, interquartile range; ns, non significant.
Following this IOL implantation, the magnitude of error 
was close to 0 and the correction index was close to 1 but 
with a slight tendency toward undercorrection. In our study, 
the absolute angle of error was 1.90°±0.69°, which seems to 
be a mean misalignment slightly better than reported with 
other types of IOLs.5,12,31–33 The angle of error obtained is not 
directly comparable to the level of rotation of 2.43°±1.55° 
measured because of the subjective component of the 
refractive outcome, the influence of incision and possibly 
the effect of other refractive surfaces of the eye (posterior 
corneal surface, vitreous).12,26,27 The low amount of residual 
refractive astigmatism obtained at 6 months follow-up is in 
accordance with the mean index of success obtained that 
was close to 0 and the mean flattening index that was close 
to 1 indicating that Precizon® toric IOL was very effective 
in reducing astigmatism at the intended meridian of treat-
ment. The relationship between toric misalignment of a 
fully-correcting IOL and residual refractive astigmatism 
is known to be sinusoidal with small deviations resulting 
in a proportional greater loss of cylinder effect.10,29,30 The 
Precizon® toric IOL Model 565 has a transitional conic 
toric surface (patent pending), where the diopter power is 
calculated per meridian in a constant diopter power from 
the center to the edge of the IOL, resulting in a broader toric 
meridian that might be more tolerant for misalignment, tilt, 
and decentration than previous standard toric IOL. Compara-
tive large-scale studies are needed to elucidate the potential 
advantage of the transitional conic toric surface of the IOL 
regarding tolerance to misalignment.
In our study, the UDVA was 0.1 logMAR or better 
in 95% of the eyes at 6 months follow-up and was equal 
or better than preoperative BCDVA in all the eyes, so 
this IOL seems to have excellent efficacy and safety 
and resulted in a very high level of patient satisfaction. 
Other studies also reported good UDVA with different 
IOLs.5–9,28–30
In accordance with functional results in our study, after 
6 months, 97.5% of the eyes were within ±0.50 D of the 
target emmetropia and the mean refractive cylinder was 
0.24±0.27 D, being 0.50 D in 95% of the eyes and 1.00 D 
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Figure 6 absolute iOl rotation between observation periods in all 40 eyes implanted 
with Precizon® toric iOl during cataract surgery.
Abbreviations: iOl, intraocular lens; w, week; m, month.
in 100% of the eyes, which is slightly better than observed 
in previous studies.5,7–9,28
The reduction in ECC is expected after phacoemulsifi-
cation technique, ranging from 4% to 18% according to the 
literature.34 The endothelial cell loss of 1.42% observed in 
our study was not regarded as an IOL-related complication. 
No complication occurred during the 6-month follow-up. 
Long-term follow-up is desirable to assess for long-term 
complications such as posterior capsule opacification and 
possible future misalignments.
Conclusion
Precizon® toric IOL appears to have very good rotational sta-
bility and performance regarding predictability and efficacy 
in the correction of preexisting corneal astigmatism during 
cataract surgery. As long as patients and IOL are carefully 
selected, there are no major safety-concerned complications. 
Patients reported a very high level of satisfaction with this 
new IOL. The toric IOL implantation can allow spectacle-
independence for distance vision and will play an increasing 
role in modern cataract surgery. Techniques to optimize 
intraoperative alignment seem to now play the key role in 
achieving even better results. Further studies with this new 
IOL are desirable to confirm our results.
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